Page 5 - Rapid Detection News Today

  Advances in testing is an extremely helpful step in controlling the COVID-19 pandemic, as increased testing access can identify cases quickly and reduce transmission.  “Screening testing, especially with the over-the-counter tests authorized today, is an important part of the country’s pandemic response—many schools, workplaces, communities, and other entities are setting up testing programs to quickly screen for COVID-19,” said Jeff Shuren, director of the FDA’s Center for Device...

April 1st, 2021 Abbott The details on COVID-19 at-home testing are changing, and in a way that could have a major impact on our ability to deal with the pandemic. The FDA has now authorized multiple rapid tests for over the counter use (meaning, without a prescription or doctor pre-approval) to screen people who dont have symptoms of the disease. According to the FDA, "The addition of the OTC and POC tests for screening will give schools, workplaces, communities and others several options for s...

Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening.

WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) said that it has received an emergency use authorization from the U.S. Food and Drug Administration for its rapid antigen test to be

BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting Reporting app helps facilitate SARS-CoV-2 testing and result reporting from BD Veritor™ Plus System News provided by Share this article Share this article FRANKLIN LAKES, N.J., March 9, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection ...

Share: Chairman and CEO Alan Jay Weisberg Issues Letter to Shareholders MIAMI, FL, March 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) ("Progressive Care," the "Company," "we," "our"), a personalized healthcare services and technology company, issues the following Letter to Shareholders from the Chief Executive Officer: Dear Valued Shareholder, We have completed another impressive year in the history of Progressive Care, Inc. I would like to share with y...

Share this article Share this article FRANKLIN LAKES, N.J., Feb. 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Scanwell Health, a leader in smartphone-enabled at-home medical tests, today announced a collaboration to create an at-home rapid test for SARS-CoV-2 using a BD antigen test and the Scanwell Health mobile app. As part of the collaboration, BD plans to produce a lateral flow antigen test and pair it with the Sc...

A peer-reviewed study indicates that the company’s antigen test could be more selective in detecting contagious COVID-19 patients than PCR testing.

COVID Test Results in 15min with New At-Home Test Service from Ready COVID Test Results in 15min with New At-Home Test Service from Ready Ready, an on-demand healthcare service, today announces in-home rapid COVID-19 testing with results in 15 minutes or less. The rapid test can be run from start to finish in the home, increasing the access to widespread testing outside of healthcare facilities. This testing capability not only reduces potential exposure at hospitals or testing sites, but also ...

Taiwan develops microfluidic platform for rapid screening of diseases Taiwan develops microfluidic platform for rapid screening of diseases 18 January 2021 | News Personalized Antibiotic Screening Platform fAST automates both genotype and phenotype detections to identify bacteria within 1.5 hours and finish the multiple antibiotics combination test within 5 hours Photo Credit: PRNewswire Taiwans Health and Biotech company MedFluid has developed the fastest, first-in-class antimicrob...